ATE269702T1 - Zusammensetzungen, kits und verfahren zur hemmung von zerebralen neurovasculären störungen und muskulärem kopfschmerzen - Google Patents

Zusammensetzungen, kits und verfahren zur hemmung von zerebralen neurovasculären störungen und muskulärem kopfschmerzen

Info

Publication number
ATE269702T1
ATE269702T1 AT98936893T AT98936893T ATE269702T1 AT E269702 T1 ATE269702 T1 AT E269702T1 AT 98936893 T AT98936893 T AT 98936893T AT 98936893 T AT98936893 T AT 98936893T AT E269702 T1 ATE269702 T1 AT E269702T1
Authority
AT
Austria
Prior art keywords
kits
compositions
methods
neurovascular disorders
cerebral neurovascular
Prior art date
Application number
AT98936893T
Other languages
English (en)
Inventor
Bruce H Levin
Original Assignee
Bruce H Levin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bruce H Levin filed Critical Bruce H Levin
Application granted granted Critical
Publication of ATE269702T1 publication Critical patent/ATE269702T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98936893T 1997-07-21 1998-07-17 Zusammensetzungen, kits und verfahren zur hemmung von zerebralen neurovasculären störungen und muskulärem kopfschmerzen ATE269702T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US89719297A 1997-07-21 1997-07-21
US7284598P 1998-01-28 1998-01-28
US8455998P 1998-05-06 1998-05-06
PCT/US1998/014870 WO1999003473A1 (en) 1997-07-21 1998-07-17 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches

Publications (1)

Publication Number Publication Date
ATE269702T1 true ATE269702T1 (de) 2004-07-15

Family

ID=27372174

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98936893T ATE269702T1 (de) 1997-07-21 1998-07-17 Zusammensetzungen, kits und verfahren zur hemmung von zerebralen neurovasculären störungen und muskulärem kopfschmerzen

Country Status (20)

Country Link
EP (1) EP0999839B1 (de)
JP (1) JP4521117B2 (de)
KR (1) KR20010022041A (de)
CN (1) CN1267219A (de)
AR (1) AR013240A1 (de)
AT (1) ATE269702T1 (de)
AU (1) AU8574398A (de)
BR (1) BR9810773A (de)
CA (1) CA2297097C (de)
DE (1) DE69824730T2 (de)
EE (1) EE200000050A (de)
HU (1) HUP0003953A3 (de)
ID (1) ID24903A (de)
IL (2) IL134087A0 (de)
IS (1) IS5349A (de)
NO (1) NO20000293L (de)
PL (1) PL338176A1 (de)
SK (1) SK187899A3 (de)
TR (1) TR200000149T2 (de)
WO (1) WO1999003473A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
JP4632499B2 (ja) * 1999-08-26 2011-02-16 武田薬品工業株式会社 鼻粘膜付着マトリックス
AU2100901A (en) * 1999-12-15 2001-06-25 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
GB9930083D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
US7117033B2 (en) 2000-05-08 2006-10-03 Brainsgate, Ltd. Stimulation for acute conditions
AU5662001A (en) 2000-05-08 2001-11-20 Brainsgate Ltd. Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the bbb and cerebral blood flow
US7640062B2 (en) 2000-05-08 2009-12-29 Brainsgate Ltd. Methods and systems for management of alzheimer's disease
US7146209B2 (en) 2000-05-08 2006-12-05 Brainsgate, Ltd. Stimulation for treating eye pathologies
US6853858B2 (en) 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
WO2004043218A2 (en) 2002-11-14 2004-05-27 Brainsgate Ltd. Surgical tools and techniques for stimulation
US7561919B2 (en) 2002-11-14 2009-07-14 Brainsgate Ltd. SPG stimulation via the greater palatine canal
WO2005062829A2 (en) 2003-12-19 2005-07-14 Advanced Bionics Corporation Skull-mounted electrical stimulation system and method for treating patients
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
US7592371B2 (en) 2004-08-18 2009-09-22 Medrx Co., Ltd. External preparation
AU2009274137B2 (en) * 2008-07-21 2013-10-31 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
DE102008037682A1 (de) 2008-08-14 2010-04-08 Strackharn, Klaus, Dr.med. Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
US9889109B2 (en) 2012-09-28 2018-02-13 St. Renatus, Llc Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
CN103432378A (zh) * 2013-08-15 2013-12-11 吕清华 一种治疗神经血管性头痛的中药
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
US10271907B2 (en) 2015-05-13 2019-04-30 Brainsgate Ltd. Implant and delivery system for neural stimulator
CN113573705A (zh) * 2018-12-19 2021-10-29 诺迪克控股公司 鼻内利多卡因的治疗组合物
WO2020152212A1 (en) * 2019-01-22 2020-07-30 Icm (Institut Du Cerveau Et De La Moelle Épinière) Local anesthetic for the treatment of neurological symptoms resulting from brain dysfunctions
GB2628149A (en) * 2023-03-16 2024-09-18 Lee Nathaniel Wurie Nasal spray for performing sphenopalatine ganglion block

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
DE19524691A1 (de) * 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
DE19526019A1 (de) * 1995-07-17 1997-01-23 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Kopfschmerzen
BE1009851A3 (fr) * 1996-01-11 1997-10-07 Thiebauld Charles Marie Composition pharmaceutique pour le traitement des cephalees et son utilisation.
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use

Also Published As

Publication number Publication date
AU8574398A (en) 1999-02-10
HUP0003953A3 (en) 2002-02-28
ID24903A (id) 2000-08-31
DE69824730D1 (de) 2004-07-29
BR9810773A (pt) 2000-09-19
CA2297097C (en) 2009-04-07
KR20010022041A (ko) 2001-03-15
PL338176A1 (en) 2000-10-09
DE69824730T2 (de) 2005-07-14
NO20000293L (no) 2000-03-20
TR200000149T2 (tr) 2000-05-22
IL134087A (en) 2006-10-31
CA2297097A1 (en) 1999-01-28
EE200000050A (et) 2000-10-16
EP0999839B1 (de) 2004-06-23
EP0999839A1 (de) 2000-05-17
JP4521117B2 (ja) 2010-08-11
CN1267219A (zh) 2000-09-20
HUP0003953A1 (hu) 2002-01-28
NO20000293D0 (no) 2000-01-20
JP2001513483A (ja) 2001-09-04
SK187899A3 (en) 2000-12-11
IS5349A (is) 2000-01-18
WO1999003473A1 (en) 1999-01-28
IL134087A0 (en) 2001-04-30
AR013240A1 (es) 2000-12-13

Similar Documents

Publication Publication Date Title
ATE269702T1 (de) Zusammensetzungen, kits und verfahren zur hemmung von zerebralen neurovasculären störungen und muskulärem kopfschmerzen
AU2862200A (en) Compositions, kits, apparatus, and methods for inhibiting cerebral neurovasculardisorders and muscular headaches
ATE278330T1 (de) Vefahren zur verbesserung der süssefreigabe von sucralose
DE69928690D1 (de) Zusammensetzung und Verfahren zur Bindung von Hautirritierenden Mitteln.
DE69939070D1 (de) Verfahren zur quantifizierung von menschlicher wachsamkeit
DE69940001D1 (de) Informationsverteilungsgerät und Informationsverteilungsverfahren, Informationsempfangsgerät und Informationsempfangsverfahren und Verfahren zum Informationsempfang und zur Informationsverteilung
DE69914773D1 (de) Verfahren zur reinigung von 1,3-propandiol
HUP0101625A3 (en) New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same
DE19781608T1 (de) Verfahren und Vorrichtungen zum Ausgeben von Zusammensetzungsmassen
DE69901885D1 (de) Vorrichtung zur cerebralen wiederbelebung
DE69716809D1 (de) Verfahren zur Getränkstabilisierung
EP1216218A4 (de) Verfahren zur anreicherung von kohlenwasserstoffen
DE69914992D1 (de) Verfahren zur Bereitstellung von Verkehrsinformationen
HUP0501017A3 (en) Methods and compositions for treatment of central nervous system disorders
DE69715234D1 (de) Verfahren zur reinigung von 1,1-difluorethan
EP1353933A4 (de) Verfahren zur reinigung von lactose
DE69710078D1 (de) Verfahren zur reinigung von 1,1,1,3,3-pentafluorpropan
EP1419236A4 (de) Verfahren zur behandlung von sklerotischen erkrankungen unter verwendung cd2-bindender substanzen
AU2001257129A1 (en) Novel pharmacotherapeutic process and composition for central nervous system disorders
EP1471818A4 (de) Verfahren und zusammensetzungen zur behandlung von hämatologischen erkrankungen unter verwendung von 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 oder 13249 molekülen
ATE206392T1 (de) Verfahren zur alkylierug von gehinderten sulfonamiden
DE69519824D1 (de) Polyimid-Toner-Zusammensetzungen, Polyimid-Herstellungsverfahren und Verfahren zur Druckfarbentfernung
DE59707440D1 (de) Verfahren zum dauerhaften verbinden von siliziumscheiben
DE50008173D1 (de) Verfahren zur Befestigung von Sitzschienen
ZA986449B (en) Compositions kits and methods for inhibiting cerebral neurovascular disorders and muscular headaches

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties